What can you take for a UTI after gastric sleeve surgery is a common and important question, as the procedure affects stomach volume and may influence how some medications are absorbed. UTIs cause uncomfortable symptoms including burning on urination, increased frequency, and cloudy urine, and require prompt treatment with the correct antibiotic. Post-bariatric patients need to consider formulation suitability, potential pharmacokinetic changes, and the importance of staying well hydrated. This article outlines UK-recommended antibiotic options, formulations to prefer or avoid, and when to seek urgent medical advice after gastric sleeve surgery.

UTIs After Gastric Sleeve Surgery: Why They Can Occur

Dehydration is the most important modifiable UTI risk factor after gastric sleeve surgery, as reduced fluid intake leads to concentrated urine that encourages bacterial growth. General risk factors such as female sex, diabetes, and catheterisation also apply.

Urinary tract infections (UTIs) are among the more common infections experienced by adults in the UK. Individuals who have undergone gastric sleeve surgery may face some additional risk factors, particularly in the early post-operative period, though a significantly elevated long-term risk has not been firmly established.

The clearest modifiable risk factor after gastric sleeve surgery is dehydration. Reduced fluid intake — whether due to discomfort, altered thirst perception, or the physical restriction of the smaller stomach — can lead to concentrated urine, which creates a more favourable environment for bacterial growth in the urinary tract. NHS bariatric services consistently emphasise the importance of adequate hydration after weight-loss surgery. In the immediate post-operative period, urinary catheterisation (used during surgery) is also a recognised short-term risk factor for UTIs.

It is worth noting that many of the general risk factors for UTIs apply equally to post-bariatric patients: these include female sex, sexual activity, the menopause, diabetes, urinary tract abnormalities, and immunosuppression. Some post-operative patients may have conditions such as type 2 diabetes that independently increase UTI risk.

Claims that nutritional deficiencies or hormonal changes after gastric sleeve surgery directly increase UTI risk are not well established in the clinical literature. Whilst maintaining good nutritional status is important for overall health and immune function, patients should not assume that micronutrient supplementation will prevent UTIs.

Symptoms of a UTI — including a burning sensation when urinating, increased frequency or urgency, cloudy or strong-smelling urine, and lower abdominal discomfort — should prompt prompt medical attention, particularly in the post-operative period. The NHS UTI patient information pages provide a helpful overview of symptoms and when to seek care.

How Gastric Sleeve Surgery Affects Medication Absorption

Gastric sleeve surgery is restrictive rather than malabsorptive, so significant intestinal malabsorption of antibiotics is not generally expected, though modest drug-specific pharmacokinetic changes may occur. Immediate-release or liquid formulations are preferred in the early post-operative period.

An important consideration when treating any condition after gastric sleeve surgery is how the procedure may affect the way some medications are absorbed. The gastric sleeve reduces the stomach's volume by approximately 75–80%, leaving a narrow, tube-shaped stomach. Unlike malabsorptive procedures such as Roux-en-Y gastric bypass, the gastric sleeve is primarily a restrictive operation and does not bypass the small intestine. As a result, significant intestinal malabsorption is not generally expected.

However, some modest, drug-specific pharmacokinetic changes may occur:

• Reduced gastric volume: Tablets and capsules spend less time in the stomach before passing into the small intestine, which may affect dissolution of some formulations

• Variable gastric acid reduction: Some patients are prescribed proton pump inhibitors (PPIs) post-operatively, which can reduce gastric acidity and affect dissolution of certain drug formulations

• Altered gastric emptying: May influence the rate of drug absorption for some medicines

Claims of broadly altered first-pass metabolism after sleeve gastrectomy are not well supported by evidence and should not be assumed. The pharmacokinetic effects of sleeve gastrectomy are modest and drug-specific, and are generally less pronounced than those seen after malabsorptive bariatric procedures.

For practical purposes, the Specialist Pharmacy Service (SPS) and the British Obesity and Metabolic Surgery Society (BOMSS) recommend that post-bariatric patients:

• Prefer immediate-release tablets or liquid formulations in the early post-operative period where clinically appropriate

• Have critical-dose or narrow-therapeutic-index medicines reviewed individually by a pharmacist or prescriber

• Ensure their surgical history (including the type of procedure) is clearly documented in their medical records and communicated to all prescribers and pharmacists

Patients should always inform their GP, pharmacist, and any other prescriber of their surgical history before being prescribed any new medication.

Antibiotics Commonly Prescribed for UTIs in the UK

NICE-recommended first-line antibiotics for uncomplicated lower UTI include nitrofurantoin MR, trimethoprim, pivmecillinam, and fosfomycin; fosfomycin's liquid sachet formulation is particularly practical after bariatric surgery. Men, pregnant women, and those with suspected pyelonephritis require different management.

In the UK, the treatment of UTIs is guided by NICE antimicrobial prescribing guidelines (NG109 for lower UTI; NG111 for pyelonephritis) and UKHSA management of infection guidance for primary care. The recommended antibiotics and durations vary depending on the patient's sex, pregnancy status, renal function, and whether the infection is confined to the lower urinary tract or involves the kidneys.

First-line options for uncomplicated lower UTI in non-pregnant women:

• Nitrofurantoin 100 mg modified-release (MR) twice daily for 3 days (if eGFR ≥45 ml/min/1.73 m²). Nitrofurantoin MR capsules are commonly used in clinical practice, including in post-bariatric patients, under prescriber guidance. It must be taken with food to aid absorption and reduce gastrointestinal side effects. Nitrofurantoin is not suitable for suspected upper urinary tract infection (pyelonephritis) and should be avoided at term in pregnancy (from 36 weeks). It should generally be avoided if eGFR is below 45 ml/min/1.73 m²; if eGFR is 30–44, a short course may be used with caution for acute uncomplicated lower UTI only — follow current BNF and MHRA guidance.

• Trimethoprim 200 mg twice daily for 3 days (if low risk of resistance). Trimethoprim is available as tablets and as an oral solution, which may be preferable for some post-bariatric patients. It should not be used if the patient has taken it in the previous three months, if local resistance rates are high, or during pregnancy (particularly the first trimester, due to folate antagonism) unless specifically advised by a clinician.

• Pivmecillinam and fosfomycin are recommended alternatives. Fosfomycin (a single 3 g sachet dissolved in water) is taken as a liquid solution, which is practical after bariatric surgery as it avoids concerns about tablet dissolution. It is available on NHS prescription. Fosfomycin is not appropriate for pyelonephritis.

Men with UTIs generally require a 7-day course of antibiotics and a urine culture should be sent before or at the start of treatment, as UTIs in men are considered complicated. Men should be assessed by a GP.

Pregnancy: UTIs in pregnancy require prompt treatment and specialist guidance; some antibiotics (including trimethoprim and nitrofurantoin at term) are contraindicated or require caution. Always inform your prescriber if you are pregnant or may be pregnant.

When to send a urine culture: A midstream urine (MSU) sample for culture and sensitivity testing is recommended for men, pregnant women, catheterised patients, those with recurrent or complicated UTIs, and anyone whose symptoms do not improve as expected.

For suspected upper urinary tract infection (pyelonephritis) — indicated by fever, loin pain, nausea, or vomiting — nitrofurantoin, trimethoprim, and fosfomycin are not appropriate. A different antibiotic class is required, and hospital assessment may be needed (see NICE NG111).

For complicated UTIs or cases where oral absorption is uncertain, your GP or bariatric team may consider intravenous antibiotics or hospital admission. Always complete the full prescribed course of antibiotics, even if symptoms improve early.

If you experience any suspected side effects from an antibiotic, report these via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Medicines and Formulations to Avoid After Gastric Sleeve

Modified-release, enteric-coated, and effervescent tablets are generally less preferred after gastric sleeve surgery due to potential dissolution issues; immediate-release tablets, liquids, and soluble sachets are favoured. NSAIDs should be avoided due to the significantly increased risk of gastric ulceration.

After gastric sleeve surgery, certain medication formulations may be less suitable due to the risk of poor dissolution, gastric irritation, or unpredictable absorption. Understanding formulation preferences is an important aspect of safe medication management in the post-bariatric period.

Formulations generally less preferred after gastric sleeve surgery:

• Modified-release (MR), extended-release (XL/XR), or sustained-release tablets: These are designed to dissolve slowly over time. In the early post-operative period, altered gastric conditions may affect their dissolution. However, this is not an absolute contraindication for all MR formulations — for example, nitrofurantoin MR capsules are commonly prescribed for UTIs in post-bariatric patients under prescriber guidance. Decisions should be made on a case-by-case basis in discussion with a pharmacist or prescriber.

• Large or enteric-coated tablets: Coating may not dissolve reliably in the reduced-acid environment of the post-sleeve stomach, particularly if a PPI is being taken.

• Effervescent tablets: High sodium content and carbonation can cause discomfort in patients with a reduced stomach capacity.

Preferred formulations where clinically appropriate include immediate-release tablets, liquid formulations, and soluble sachets. Where liquid antibiotics are used, sugar-free formulations should be requested where possible, to avoid excess sugar intake and reduce the risk of dumping syndrome.

NSAIDs (e.g., ibuprofen) are strongly discouraged after bariatric surgery due to the significantly increased risk of gastric ulceration and gastritis. They should be avoided unless specifically prescribed under clinical supervision, usually with gastroprotection (a PPI). Paracetamol is the preferred analgesic for pain relief associated with UTI symptoms.

Patients should always inform their pharmacist and GP of their surgical history — including the type of bariatric procedure — when collecting or requesting any prescription. BOMSS guidance recommends that bariatric patients carry a medication alert card and that all prescribers are made aware of their surgical status to ensure safe and effective prescribing. The SPS (Specialist Pharmacy Service) also provides practical guidance on using medicines after bariatric surgery.

When to Seek Advice from Your GP or Bariatric Team

Post-bariatric patients should contact their GP promptly at the onset of UTI symptoms rather than self-treating, as altered physiology may affect standard approaches. Seek urgent care or call 999 if signs of sepsis, loin pain, or inability to keep fluids down develop.

Whilst mild, uncomplicated UTIs can sometimes be managed with self-care measures in the general population, post-bariatric patients are advised to seek professional medical advice promptly when UTI symptoms arise. The altered physiology following gastric sleeve surgery means that standard self-treatment approaches may not be appropriate, and under-treated infection can progress to a more serious condition.

Contact your GP promptly if you experience:

• Burning or pain when urinating

• Increased frequency or urgency of urination

• Cloudy, dark, or strong-smelling urine

• Lower abdominal or pelvic discomfort

• Blood in the urine (haematuria)

Certain groups should seek same-day assessment rather than waiting for a routine appointment. These include men, pregnant women, children, people who are immunosuppressed, those with a urinary catheter, and anyone with known urinary tract abnormalities. If you are in one of these groups, contact your GP or call NHS 111 on the same day symptoms begin.

Seek urgent medical attention or call 999 if you develop signs that may suggest sepsis:

• High temperature (above 38°C) or feeling very cold and shivery

• Rapid breathing or heart rate

• Confusion, disorientation, or slurred speech

• A rash that does not fade when pressed

• Feeling extremely unwell or that something is seriously wrong

Call NHS 111 or seek urgent care if you develop:

• Loin or back pain (which may suggest kidney involvement/pyelonephritis)

• Nausea, vomiting, or inability to keep fluids down

• Symptoms that are not improving after 48 hours of antibiotic treatment

If you notice blood in your urine that persists after completing antibiotic treatment, or if you experience recurrent episodes of visible haematuria, inform your GP, as further investigation may be needed.

It is also advisable to contact your bariatric team or specialist nurse if you are unsure whether a prescribed antibiotic is appropriate for your post-operative status, or if you are experiencing recurrent UTIs. Recurrent infections may warrant urine culture and sensitivity testing to ensure the correct antibiotic is being used and to rule out any underlying factors.

Over-the-counter urinary alkalinising sachets (such as those containing sodium citrate) may provide symptomatic relief only — they do not treat the underlying infection. Post-bariatric patients should check with their pharmacist before using these products, as high sodium content may cause discomfort. They are not a substitute for antibiotic treatment prescribed by a clinician.

Preventing UTIs Following Bariatric Surgery

Adequate hydration — at least 1.5–2 litres of fluid daily in small sips — is the single most important preventive measure against UTIs after gastric sleeve surgery. NICE also recommends methenamine hippurate and topical vaginal oestrogen for women with recurrent UTIs.

Prevention is always preferable to treatment, and there are several evidence-informed strategies that post-bariatric patients can adopt to reduce their risk of developing UTIs.

Hydration is the single most important preventive measure. Adequate fluid intake helps to flush bacteria from the urinary tract and prevents the concentrated urine that encourages bacterial growth. Post-bariatric guidelines typically recommend a minimum of 1.5 to 2 litres of fluid per day, taken in small, frequent sips rather than large volumes at once. Water, diluted squash, and herbal teas are all suitable choices. Caffeinated and carbonated drinks should be limited, as these can irritate the bladder. Important caveat: if you have been advised by a clinician to restrict your fluid intake (for example, due to heart failure or kidney disease), follow your clinician's specific guidance rather than general targets.

Maintaining good personal hygiene — including wiping front to back after using the toilet and urinating after sexual intercourse — remains important for reducing the risk of bacterial entry into the urethra, particularly in women. Wearing breathable, cotton underwear and avoiding tight-fitting clothing can also help.

Nutritional supplementation as recommended by your bariatric team is important for overall health and immune function. All patients who have undergone gastric sleeve surgery should take the bariatric-specific vitamin and mineral supplements advised by their dietitian or bariatric nurse (in line with BOMSS guidance). Whilst good nutritional status supports general health, patients should not assume that specific supplements such as vitamin C or zinc will directly prevent UTIs — the evidence for this is not established.

For women with recurrent UTIs, a GP may consider the following options in line with NICE guidance (NG112):

• Methenamine hippurate — a non-antibiotic option recommended by NICE (NG112) as an antibiotic-sparing prophylaxis for recurrent UTIs in women. It works by acidifying the urine and is taken regularly to reduce recurrence.

• Topical vaginal oestrogen — recommended by NICE for post-menopausal women with recurrent UTIs, as it helps restore the vaginal and urethral microenvironment.

• Low-dose prophylactic antibiotics — reserved for selected cases where other measures have not been effective, in line with NICE NG112.

Cranberry products and D-mannose are sometimes used by patients for UTI prevention. The evidence for their effectiveness is limited and they are not formally recommended by NICE. If you wish to try these, discuss with your GP or pharmacist first — cranberry products can interact with anticoagulants such as warfarin, and many commercial preparations contain significant amounts of sugar, which may be a concern after bariatric surgery. Sugar-free formulations are preferable.

Worried about interactions with other medications? Speak to one of our pharmacists →

If you suspect a side effect from any medicine used to prevent or treat a UTI, report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Frequently Asked Questions